Sales Of Drug-Spiked Supplements After Warnings Show Stronger US Regulation Needed – Study

"FDA should consider ways to ensure that prohibited drugs are removed from supplements, perhaps by testing products sold after warning letters and mandating recalls whenever products remain adulterated,” say Pieter Cohen and colleagues in JAMA study.

• Source: Shutterstock

More from Compliance

More from Policy & Regulation